Monopar Therapeutics Common Stock share price logo

Monopar Therapeutics Common Stock

NASDAQ: MNPR

Small Cap

$87.77

+6.00

(+7.34%)

as on

Monopar Therapeutics Common Stock Stock Performance

as on June 25, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $82.04
    $88.60
    downward going graph

    6.53%

    Downside

    0.95%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $29.18
    $105.00
    downward going graph

    66.75%

    Downside

    19.63%

    Upside

    downward going graph

Monopar Therapeutics Common Stock share price movements today

Previous Close
$81.77
Open
$82.04
Volume
318.9K
Day's Low - High
$82.04 - $88.60
52 Week Low - High
$29.18 - $105.00

Monopar Therapeutics Common Stock Historical Returns

1 Month Return
+ 29.55 %
3 Month Return
+ 48 %
1 Year Return
+ 145.56 %
3 Year Return
+ 1779.77 %
5 Year Return
+ 151.99 %

Monopar Therapeutics Common Stock Stock Fundamentals & Key Indicators

Check Monopar Therapeutics Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$460.0M

EPS (TTM)

-2.9037

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-15.86%

Monopar Therapeutics Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Monopar Therapeutics Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$460.0M151.99%NA0.00%NA
BUY$38.2B65.93%71.9612.55%NA
BUY$118.5B144.05%27.735.51%NA
BUY$64.2B13.51%14.9529.65%0.59%

Stock Returns calculator for Monopar Therapeutics Common Stock Stock including INR - Dollar returns

The Monopar Therapeutics Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Monopar Therapeutics Common Stock investment value today

Current value as on today

₹2,90,321

Returns

₹1,90,321

(+190.32%)

Returns from Monopar Therapeutics Common Stock Stock

₹1,63,574 (+163.57%)

Dollar Impact

₹26,747 (+26.75%)

Analyst Recommendation on Monopar Therapeutics Common Stock Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Monopar Therapeutics Common Stock. Average target price of $112.62

Monopar Therapeutics Common Stock Share Price Target

Get share price movements and forecasts by analysts on Monopar Therapeutics Common Stock.

What analysts predicted

22.07%UPSIDE

Target Price

$112.62

Current Price

$87.77

Analyzed by

8 Analysts

Target

$112.62

Monopar Therapeutics Common Stock target price $112.62, a slight upside of 22.07% compared to current price of $87.77. According to 8 analysts rating.

Indian Investors' Interest in Monopar Therapeutics Common Stock Stock

Search interest for Monopar Therapeutics Common Stock Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Monopar Therapeutics Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-1
-1
-1
-1
-11
-3
-3
-4
-6
-5
EBITDA
0
-1
-1
-1
-10
-2
-2
-4
-5
-3
Interest Expense
0
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
-1
-1
-1
-10
-2
-2
-3
-5
-3
Income Tax Expense
0
-1
-1
-
-
-
-
-
-
-
Net Income
-1
-1
-1
-1
-10
-2
-2
-3
-5
-3
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Monopar Therapeutics Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
0
-
-
-
-
-
Gross Profit
-
-
-
-
0
-
-
-
-
-
Operating Income
-1
-16
-3
-4
-6
-9
-10
-8
-16
-16
EBITDA
-1
-16
-3
-4
-6
-9
-10
-8
-15
-13
Interest Expense
0
0
0
0
0
0
0
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-1
-16
-3
-4
-6
-9
-10
-8
-15
-13
Income Tax Expense
0
-2
0
0
0
0
0
0
-
-
Net Income
-1
-16
-3
-4
-6
-9
-10
-8
-15
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-5150.79%
0.00%
0.00%
0.00%
0.00%
0.00%

Monopar Therapeutics Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1
-1
-1
-10
-2
-2
-3
-5
-3
Operating Cash Flow
-1
-1
-1
-1
-5
-1
-2
-3
-3
Investing Cash Flow
0
0
0
-14
0
1
-2
-62
-5
Financing Cash Flow
3
0
0
56
0
0
92
0
0
Change in Cash
0
-1
0
39
-6
0
88
-65
-9

Monopar Therapeutics Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-3
-4
-6
-9
-10
-8
-15
-13
Operating Cash Flow
-2
-2
-3
-4
-7
-7
-7
-6
-12
Investing Cash Flow
-
-
-
-
-
-4
4
-14
-63
Financing Cash Flow
9
0
9
8
10
0
2
59
91
Change in Cash
6
-2
6
3
3
-12
0
38
16

Global Institutional Holdings in Monopar Therapeutics Common Stock

Funds
Holdings
Adage Capital Partners Gp LLC
4.62%
Charles Schwab Investment Management Inc
0.21%
Vanguard Capital Management, LLC
3.26%
Susquehanna International Group, LLP
0.14%
Bank of New York Mellon Corp
1.17%

Monopar Therapeutics Common Stock News & Key Events

    Insights on Monopar Therapeutics Common Stock

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Best in 1 Year

      img

      In the last 1 year, MNPR has outperformed top 5 stocks with highest market-cap in its industry

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 7 days, MNPR stock has moved up by 21.2%

    • imgPOSITIVE IMPACT

      Best in 3 Years

      img

      In the last 3 years, MNPR has outperformed top 5 stocks with highest market-cap in its industry

    About Monopar Therapeutics Common Stock

    Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, which is in phase 1 imaging and dosimetry clinical trial, a radiopharmaceutical imaging agent comprised of MNPR-101 conjugated to zirconium-89. It develops MNPR-101-Lu, a Phase1a stage radiotherapeutic comprised of MNPR-101 conjugated to actinium-225. The company has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; Excel Diagnostics and Nuclear Oncology Center, for the investigational imaging agent MNPR-101-Zr and investigational therapeutic agent MNPR-101-Lu; license agreement with Alexion to develop and commercialize ALXN1840, a drug candidate for Wilson disease. The company was founded in 2014 and is headquartered in Wilmette, Illinois.
    OrganisationMonopar Therapeutics Common Stock
    Headquarters1000 Skokie Boulevard, Wilmette, IL, United States, 60091
    IndustryBiotechnology
    CEODr. Chandler D. Robinson M.B.A., M.D., M.Sc.
    E-voting on sharesClick here to vote

    Key Management of Monopar Therapeutics Common Stock

    Name

    Title

    Dr. Christopher M. Starr Ph.D.

    Co-Founder & Independent Executive Chairman of the Board

    Dr. Chandler D. Robinson M.B.A., M.D., M.Sc.

    Co-Founder, CEO, President & Director

    Mr. Quan Anh Vu

    CFO, Principal accounting officer, Principal financial officer, Secretary & Treasurer

    Mr. Andrew J. Cittadine M.B.A.

    Chief Operating Officer

    Dr. Patrice P. Rioux M.D., Ph.D.

    Acting Chief Medical Officer

    Ms. Susan Rodriguez

    Chief Commercial & Strategy Officer

    FAQs

    What is Monopar Therapeutics Common Stock share price today?

    Monopar Therapeutics Common Stock share price today is $87.77 as on at the close of the market. Monopar Therapeutics Common Stock share today touched a day high of $88.6 and a low of $82.04.

    What is the 52 week high and 52 week low for Monopar Therapeutics Common Stock share?

    Monopar Therapeutics Common Stock share touched a 52 week high of $105 on and a 52 week low of $29.18 on . Monopar Therapeutics Common Stock stock price today i.e. is closed at $87.77,which is 16.41% down from its 52 week high and 200.79% up from its 52 week low.

    What is Monopar Therapeutics Common Stock's market capitalisation today?

    Monopar Therapeutics Common Stock market capitalisation is $0.00T as on .

    How to invest in Monopar Therapeutics Common Stock Stock (MNPR) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for Monopar Therapeutics Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Monopar Therapeutics Common Stock Shares that will get you 0.0171 shares as per Monopar Therapeutics Common Stock share price of $87.77 per share as on June 25, 2026 at 1:29 am IST.

    What is the minimum amount required to buy Monopar Therapeutics Common Stock Stock (MNPR) from India?

    Indian investors can start investing in Monopar Therapeutics Common Stock (MNPR) shares with as little as ₹94.665 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹946.65 in Monopar Therapeutics Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Monopar Therapeutics Common Stock share’s latest price of $87.77 as on June 25, 2026 at 1:29 am IST, you will get 0.1139 shares of Monopar Therapeutics Common Stock. Learn more about fractional shares .

    What are the returns that Monopar Therapeutics Common Stock has given to Indian investors in the last 5 years?

    Monopar Therapeutics Common Stock stock has given 151.99% share price returns and 27.62% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?